Know Cancer

or
forgot password

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer


Phase 1
N/A
N/A
Open (Enrolling)
Male
Prostatic Neoplasms

Thank you

Trial Information

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer


Our initial assessment indicates that electromagnetic radiation of the central nervous
system, the viscera and the endocrine system has the potential to cure a number of diseases,
including prostate cancer.


Inclusion Criteria:



- Persons with Prostate, Bladder or Testicular Cancer.

Exclusion Criteria:

- None

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.

Outcome Time Frame:

2 years and 6 months

Safety Issue:

No

Principal Investigator

Ken Nedd, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

GAAD Medical Research Institute Inc.

Authority:

Canada: Health Canada

Study ID:

GAAD-PC-CTP1

NCT ID:

NCT00573820

Start Date:

January 2006

Completion Date:

December 2008

Related Keywords:

  • Prostatic Neoplasms
  • Tumors or cancer of the prostate
  • Cancer of Prostate
  • Cancer of the Prostate
  • Neoplasms, Prostate
  • Neoplasms, Prostatic
  • Prostate Cancer
  • Prostate Neoplasms
  • Prostatic Cancer
  • Neoplasms
  • Prostatic Neoplasms

Name

Location